Global Cancer Immunotherapy Market

Snehal Lokhande03 Apr, 2019Business

Global Cancer Immunotherapy Market is expected to reach 170.29 Billion by 2024 from 61.4 Billion in 2016 at CAGR of 13.6% (Detailed analysis of the market CAGR is provided in the report). Global Cancer Immunotherapy Market is segmented by product type, usage, application type, and geography. Growing demand for therapies with minimal adverse effects, enhanced drug development process, rising incidence of cancer, and an increase in adoption of immunotherapy over other treatment options are the major driving factors for the market growth. However, stringent regulatory policies is a key restraining factor for market growth. The Hospital sub-segment is expected to gain the largest market share during the forecast period. The rise in healthcare spending has resulted in the increasing use of drugs in hospitals. Checkpoint inhibitors segment is estimated to experience the significant growth at the highest CAGR during the forecast period. This growth is attributed to increased efficiency.